Breaking News
0

Myriad Genetics Inc (MYGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Myriad Genetics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
29.51 +0.67    +2.32%
11/10 - Closed. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US62855J1043 
CUSIP: 62855J104
  • Volume: 508,752
  • Bid/Ask: 16.10 / 30.00
  • Day's Range: 29.10 - 29.96
Myriad Genetics 29.51 +0.67 +2.32%

MYGN Overview

 
This is the main Myriad Genetics Inc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close28.84
Day's Range29.1 - 29.96
Revenue851.1M
Open29.23
52 wk Range22.04 - 48.4
EPS0.06
Volume508,752
Market Cap2.18B
Dividend (Yield)N/A (N/A)
Average Vol. (3m)1,385,180
P/E Ratio488.82
Beta0.94
1-Year Change - 32.16%
Shares Outstanding73,866,119
Next Earnings DateNov 05, 2019
What is your sentiment on Myriad Genetics?
or
Market is currently closed. Voting is open during market hours.

Myriad Genetics Inc News


Myriad Genetics Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Neutral Buy Buy Neutral
Technical Indicators Strong Sell Sell Strong Buy Strong Buy Strong Sell
Summary Strong Sell Neutral Strong Buy Strong Buy Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish Hammer 15 Current
Completed Patterns
Engulfing Bearish 1M 2 Aug 19
Upside Tasuki Gap Bullish 1H 4 Oct 11, 2019 11:00AM
Bullish Engulfing 1D 6 Oct 03, 2019

Myriad Genetics Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 29.51 16.10 30.00 508,752 +2.32% USD 11/10  
  Berlin 26.600 26.600 26.800 0 +1.53% EUR 02:08:00  
  Munich 26.800 26.600 26.800 0 +0.00% EUR 07:53:00  
  Stuttgart 26.800 22.840 23.130 0 0.00% EUR 11/10  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 236.21 237.64 232.31 +6.12 +2.66% 41.99M 11/10  
  Facebook 184.19 186.49 182.14 +4.16 +2.31% 15.00M 11/10  
  Alphabet A 1,215.71 1,228.75 1,213.64 +6.24 +0.52% 1.13M 11/10  
  Tesla 247.89 251.08 246.81 +3.15 +1.29% 8.49M 11/10  
  Netflix 282.93 287.87 275.89 +2.45 +0.87% 8.82M 11/10  
  Microsoft 139.68 141.03 139.50 +0.58 +0.42% 25.55M 11/10  
  Amazon.com 1,731.92 1,745.45 1,729.86 +11.66 +0.68% 3.28M 11/10  
  IBM 142.76 144.50 142.61 +1.63 +1.16% 3.02M 11/10  
  Visa A 177.06 179.20 176.85 +2.18 +1.25% 8.95M 11/10  
  Alibaba ADR 172.94 174.88 169.57 +6.87 +4.14% 19.37M 11/10  

Myriad Genetics Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

2600

Equity Type

ORD

Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to enable optimal treatment, or assess a patient's risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. Its molecular diagnostic tests include myRisk Hereditary Cancer, BRACAnalysis CDx and COLARIS.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
Securities Investor Protection Corporation (United States) $0 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MYGN Comments

Write your thoughts about Myriad Genetics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email